Sigma Planning Corp’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,801
Closed -$281K 1108
2019
Q4
$281K Sell
15,801
-282
-2% -$5.53K 0.01% 829
2019
Q3
$318K Buy
16,083
+11
+0.1% +$217 0.02% 741
2019
Q2
$309K Hold
16,072
0.02% 719
2019
Q1
$307K Buy
16,072
+6,618
+70% +$129K 0.02% 664
2018
Q4
$201K Buy
9,454
+146
+2% +$4.65K 0.01% 766
2018
Q3
$424K Buy
9,308
+1,375
+17% +$55.5K 0.02% 542
2018
Q2
$316K Buy
7,933
+1,323
+20% +$57.6K 0.02% 621
2018
Q1
$305K Buy
6,610
+3,468
+110% +$154K 0.02% 602
2017
Q4
$144K Buy
+3,142
New +$104K 0.01% 801

Other funds holding VANI

Sigma Planning Corp's VANI Position: Q1 2020 in Review

Sigma Planning Corp sold out of Vivani Medical (VANI) in Q1 2020, closing a stake of 15,801 shares — an estimated $281K sold.

Sigma Planning Corp first reported a position in VANI in Q4 2017 and held it in 9 quarters. The position peaked at $424K in Q3 2018. 21 funds tracked by Wall St. Rank hold VANI as of Q1 2020.

  • Sigma Planning Corp reported no remaining Vivani Medical position as of Q1 2020 after selling out during the quarter.
  • Sigma Planning Corp sold 15,801 Vivani Medical shares in Q1 2020, an estimated $281K.
  • Sigma Planning Corp first reported a position in Vivani Medical in Q4 2017 and held it in 9 quarters.
  • Sigma Planning Corp's Vivani Medical position peaked at $424K in Q3 2018.
  • 21 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2020.

Based on Sigma Planning Corp's 13F filing for Q1 2020, filed 1 May 2020.